Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ODF
|
||||
Drug Name |
LY-3390334
|
||||
Synonyms |
LY-3390334; 206444-72-6; LY-3390334; LY-339840; LY-367366; LY-393053
|
||||
Indication | Unspecified | Investigative | [1560330] | ||
Target and Pathway | |||||
Target(s) | Metabotropicglutamate receptor 1 | Target Info | Modulator | ||
Metabotropic glutamate receptor 5 | Target Info | Modulator | |||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Metabotropic glutamate receptor group III pathway | |||||
Metabotropic glutamate receptor group I pathway | |||||
Endogenous cannabinoid signalingP00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Endogenous cannabinoid signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.